FDA Advisory Committee Votes 19 to 10 In Favor of Rescheduling Combination Hydrocodone (FDA)

From FDA Law Blog: Last Friday, January 25, 2012, after two days of discussion and deliberation, an FDA Advisory Committee voted 19 to 10 in favor of rescheduling combination hydrocodone from its current placement in Schedule III to Schedule II.

Read more ›